Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senthil Selvaraj

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
CNS & Neurological Disorders Drug Targets|March 6, 2010
TRPC channels and their implication in neurological diseasesSenthil Selvaraj, Yuyang Sun, Brij B Singh
PET Clinics|November 21, 2020
Potential Cardiovascular Applications of Total-body PET ImagingJose A Rodriguez, Senthil Selvaraj, Paco E Bravo
Current Opinion in Cardiology|March 12, 2021
Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?Peder L Myhre, Senthil Selvaraj, Scott D Solomon
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 2, 2021
Cardiopulmonary transit time: Reinforcing the case for positron emission tomography after heart transplantationMahesh K Vidula, Senthil Selvaraj, Marie A Guerraty
JACC. Heart Failure|April 4, 2026
From Fuel to Flow: Translating the Beneficial Hemodynamic Effects of Exogenous Ketones in the ICUDavid M Elliott, Jason N Katz, Senthil Selvaraj
Cell Calcium|August 22, 2009
TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+)Senthil Selvaraj, John A Watt, Brij B Singh
Circulation|March 13, 2023
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF"Senthil Selvaraj, Mikhail N Kosiborod, Svati H Shah
Circulation|June 2, 2020
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart FailureSenthil Selvaraj, Daniel P Kelly, Kenneth B Margulies
European Journal of Heart Failure|November 8, 2024
Metabolic dysfunction: An important driver of incident heart failure with preserved and reduced ejection fractionJohn W Ostrominski, Petar M Seferović, Senthil Selvaraj
Molecular Carcinogenesis|April 29, 2015
Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathwaySenthil Selvaraj, Yuyang Sun, Pramod Sukumaran, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
CNS & Neurological Disorders Drug Targets|March 6, 2010
TRPC channels and their implication in neurological diseasesSenthil Selvaraj, Yuyang Sun, Brij B Singh
PET Clinics|November 21, 2020
Potential Cardiovascular Applications of Total-body PET ImagingJose A Rodriguez, Senthil Selvaraj, Paco E Bravo
Current Opinion in Cardiology|March 12, 2021
Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?Peder L Myhre, Senthil Selvaraj, Scott D Solomon
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 2, 2021
Cardiopulmonary transit time: Reinforcing the case for positron emission tomography after heart transplantationMahesh K Vidula, Senthil Selvaraj, Marie A Guerraty
JACC. Heart Failure|April 4, 2026
From Fuel to Flow: Translating the Beneficial Hemodynamic Effects of Exogenous Ketones in the ICUDavid M Elliott, Jason N Katz, Senthil Selvaraj
Cell Calcium|August 22, 2009
TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+)Senthil Selvaraj, John A Watt, Brij B Singh
Circulation|March 13, 2023
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF"Senthil Selvaraj, Mikhail N Kosiborod, Svati H Shah
Circulation|June 2, 2020
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart FailureSenthil Selvaraj, Daniel P Kelly, Kenneth B Margulies
European Journal of Heart Failure|November 8, 2024
Metabolic dysfunction: An important driver of incident heart failure with preserved and reduced ejection fractionJohn W Ostrominski, Petar M Seferović, Senthil Selvaraj
Molecular Carcinogenesis|April 29, 2015
Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathwaySenthil Selvaraj, Yuyang Sun, Pramod Sukumaran, et al.
Pageof 12